按种族和民族分组监测COVID-19结局与疫苗接种覆盖率的替代方法
CDC比较了当前按种族和民族分组的方法与两种替代方法(A和B),用于分析COVID-19病例和疫苗接种数据。当民族信息缺失时,替代方法利用种族信息,导致各类别病例和完全接种人数计数更高。不同方法对差异的结论不同,提示不完整数据下分析方法影响差异评估。
要点
- 当民族数据缺失时,替代分组方法可提高种族类别中病例和接种人数的计数。
- 方法B下AI/AN病例相对增幅最大(58.5%),NH/PI完全接种人数相对增幅最大(51.6%)。
- 不同方法下种族差异的结论可能不同,需谨慎解读不完整数据。
核心结论
- 当种族和民族数据不完整时,采用替代分组方法可能导致对COVID-19差异的不同结论。
- 这些方法存在局限性,需进一步评估潜在偏倚并咨询专家。
研究设计与样本
- 使用CDC可获得的COVID-19病例和疫苗接种数据,比较当前分组方法与两种替代方法(A和B)。
- 当前方法优先考虑民族,方法A在民族未知时假定为非西班牙裔并使用相同分母,方法B使用非互斥的种族和民族类别。
主要发现
- 与当前方法相比,替代方法导致五个种族类别(AI/AN、Asian、Black、NH/PI、White)的COVID-19病例和完全接种人数计数更高。
- 使用方法B时,AI/AN病例相对增幅最大(58.5%),NH/PI完全接种人数相对增幅最大(51.6%)。
- 方法A导致五个种族组的累积发病率和疫苗接种覆盖率更高;方法B导致AI/AN和NH/PI累积发病率下降,AI/AN累积疫苗接种覆盖率下降。
- 所有三种方法中,Asian的病例率比<1,其他组>1;NH/PI完全接种的可能性最高。
临床怎么用
- 在监测COVID-19差异时,应意识到种族和民族数据不完整及分组方法对结果的影响。
- 解读差异时应考虑方法学选择,并谨慎比较不同方法得出的率。
局限性
- 替代方法存在局限性,需进一步检查潜在偏倚。
- 需要咨询专家以确定更多分析不完整种族和民族数据的方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Population-based analyses of COVID-19 data, by race and ethnicity can identify and monitor disparities in COVID-19 outcomes and vaccination coverage. CDC recommends that information about race and ethnicity be collected to identify disparities and ensure equitable access to protective measures such as vaccines; however, this information is often missing in COVID-19 data reported to CDC. Baseline data collection requirements of the Office of Management and Budget's Standards for the Classification of Federal Data on Race and Ethnicity (Statistical Policy Directive No. 15) include two ethnicity categories and a minimum of five race categories (1). Using available COVID-19 case and vaccination data, CDC compared the current method for grouping persons by race and ethnicity, which prioritizes ethnicity (in alignment with the policy directive), with two alternative methods (methods A and B) that used race information when ethnicity information was missing. Method A assumed non-Hispanic ethnicity when ethnicity data were unknown or missing and used the same population groupings (denominators) for rate calculations as the current method (Hispanic persons for the Hispanic group and race category and non-Hispanic persons for the different racial groups). Method B grouped persons into ethnicity and race categories that are not mutually exclusive, unlike the current method and method A. Denominators for rate calculations using method B were Hispanic persons for the Hispanic group and persons of Hispanic or non-Hispanic ethnicity for the different racial groups. Compared with the current method, the alternative methods resulted in higher counts of COVID-19 cases and fully vaccinated persons across race categories (American Indian or Alaska Native [AI/AN], Asian, Black or African American [Black], Native Hawaiian or Other Pacific Islander [NH/PI], and White persons). When method B was used, the largest relative increase in cases (58.5%) was among AI/AN persons and the largest relative increase in the number of those fully vaccinated persons was among NH/PI persons (51.6%). Compared with the current method, method A resulted in higher cumulative incidence and vaccination coverage rates for the five racial groups. Method B resulted in decreasing cumulative incidence rates for two groups (AI/AN and NH/PI persons) and decreasing cumulative vaccination coverage rates for AI/AN persons. The rate ratio for having a case of COVID-19 by racial and ethnic group compared with that for White persons varied by method but was <1 for Asian persons and >1 for other groups across all three methods. The likelihood of being fully vaccinated was highest among NH/PI persons across all three methods. This analysis demonstrates that alternative methods for analyzing race and ethnicity data when data are incomplete can lead to different conclusions about disparities. These methods have limitations, however, and warrant further examination of potential bias and consultation with experts to identify additional methods for analyzing and tracking disparities when race and ethnicity data are incomplete.
引用
- Yoon P, Hall J, Fuld J, et al. Alternative Methods for Grouping Race and Ethnicity to Monitor COVID-19 Outcomes and Vaccination Coverage. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34383729. doi:10.15585/mmwr.mm7032a2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。